Skip to main content

Table 1 Description of the clinical-pathological characteristics of the cohort of Ovarian Cancer patients (M&M for details on categories reported)

From: BRCA germline mutation test for all woman with ovarian cancer?

Histology N (%)
Serous Epithelial 1312 (59,8)
Mucinous 143 (6,5)
Endometrioid 322 (14,7)
Clear Cell 201 (9,2)
Mixed 98 (4,5)
Other Epithelial (Brunner) 79 (3,6)
Undifferentiatied 5 (0,2)
N/A 32 (1,3)
Disease Stage FIGO
 1 523 (23,9)
 2 249 (11,4)
 3 1103 (50,3)
 4 25 (1,1)
 N/A 292 (13,3)
Grade Differentiation
 Well 447 (20,4)
 Moderately 261 (11,9)
 Poorly 1255 (57,2)
 Undifferentiated 15 (0,7)
 N/A 214 (9,8)
Ovarian Cancer family History
 No 1718 (78,4)
 Yes 107 (4,9)
 N/A 367 (16,7)
Breast Cancer Family History
 No 1519 (69,2)
 Yes 319 (14,5)
 N/A 354 (16,1)
BRCA1/2 alterations
 Present 182 (8,4)
 Absent 2010 (91,6)